Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Cecilia Isaksson"'
Autor:
Holger W. Auner, Simona Iacobelli, Giulia Sbianchi, Cora Knol-Bout, Didier Blaise, Nigel H. Russell, Jane F. Apperley, David Pohlreich, Paul V. Browne, Guido Kobbe, Cecilia Isaksson, Stig Lenhoff, Christof Scheid, Cyrille Touzeau, Esa Jantunen, Achilles Anagnostopoulos, Ibrahim Yakoub-Agha, Alina Tanase, Nicolaas Schaap, Wieslaw Wiktor-Jedrzejczak, Marta Krejci, Stefan O. Schönland, Curly Morris, Laurent Garderet, Nicolaus Kröger
Publikováno v:
Haematologica, Vol 103, Iss 3 (2018)
Melphalan at a dose of 200 mg/m2 is standard conditioning prior to autologous hematopoietic stem cell transplantation for multiple myeloma, but a dose of 140 mg/m2 is often used in clinical practice in patients perceived to be at risk of excess toxic
Externí odkaz:
https://doaj.org/article/f705fa443a5b491689e9661527014272
Autor:
Krista Vaht, Magnus Göransson, Kristina Carlson, Cecilia Isaksson, Stig Lenhoff, Anna Sandstedt, Bertil Uggla, Jacek Winiarski, Per Ljungman, Mats Brune, Per-Ola Andersson
Publikováno v:
Haematologica, Vol 102, Iss 10 (2017)
A plastic anemia is a rare life-threatening disease. However, since the introduction of immunosuppressive therapy and allogeneic stem cell transplantation, the outcome has improved considerably, and the 5-year survival is reported to be 70–80% in s
Externí odkaz:
https://doaj.org/article/740a3fb1ddfb44c48041c4ac3f748e50
Autor:
Patrick John Hayden, Dirk-Jan Eikema, Linda Koster, John A Snowden, Denis Caillot, Gwendolyn Van Gorkom, Laimonas Griskevicius, William Arcese, Charles Crawley, Maurizio Musso, Claude-Eric Bulabois, Alexander M Martin, Tanja Netelenbos, Andrew McDonald, Johan Maertens, Matteo Parma, Arpad Illes, Cecilia Isaksson, Claudia Sossa, Joanna Drozd-Sokolowska, Kavita Raj, Meral Beksac, Stefan Schönland, Donal P. McLornan, Ibrahim Yakoub-Agha
Publikováno v:
Blood. 140:10434-10436
Autor:
Rafal Machowicz, Felipe Suarez, Wieslaw Wiktor-Jedrzejczak, Diderik-Jan Eikema, Liesbeth C. de Wreede, Henric-Jan Blok, Cecilia Isaksson, Hermann Einsele, Xavier Poiré, Suzanne van Dorp, Emmanouil Nikolousis, Jan-Erik Johansson, Guido Kobbe, Marco Zecca, Renate Arnold, Armin Gerbitz, Jürgen Finke, Jose Luis Díez-Martín, Francesca Bonifazi, Grant McQuaker, Stig Lenhoff, Pierre-Simon Rohrlich, Matthias Theobald, Per Ljungman, Matthew Collin, Michael H. Albert, Gerhard Ehninger, Kristina Carlson, Kazimierz Halaburda, Kai Lehmberg, Stefan Schönland, Ibrahim Yakoub-Agha, Andrew R. Gennery, Arjan C. Lankester, Nicolaus Kröger
Publikováno v:
Bone Marrow Transplantation, 57, 817-823
Bone Marrow Transplantation, 57, 5, pp. 817-823
Bone marrow transplantation, Vol. 57, no.5, p. 817-823 (2022)
Bone Marrow Transplantation, 57(5), 817-823. SPRINGERNATURE
Bone Marrow Transplantation, 57, 5, pp. 817-823
Bone marrow transplantation, Vol. 57, no.5, p. 817-823 (2022)
Bone Marrow Transplantation, 57(5), 817-823. SPRINGERNATURE
Contains fulltext : 251601.pdf (Publisher’s version ) (Closed access) Hemophagocytic lymphohistiocytosis (HLH; hemophagocytic syndrome) is a rare syndrome of potentially fatal, uncontrolled hyperinflammation. Allogeneic hematopoietic stem cell tran
Autor:
Laurent Garderet, Meral Beksac, Cecilia Isaksson, Stig Lenhoff, Xavier Poiré, Alina Tanase, Giulia Sbianchi, Soledad González Muñiz, Jenny Byrne, Jane F. Apperley, Paul Browne, Linda Koster, Simona Iacobelli, Arnon Nagler, Ibrahim Yakoub-Agha, Jiri Mayer, Cyrille Touzeau, Marek Trneny, Rocio Parody Porras, Grzegorz W. Basak, Patrick Hayden, Didier Blaise, Mariagrazia Michieli, Péter Reményi, Stefan Schönland
Publikováno v:
European journal of haematology, Vol. 106, no.5, p. 708-715 (2021)
Background In autologous stem cell transplant (ASCT)-eligible myeloma patients, prolonged induction does not necessarily improve the depth of response. Method We analysed 1,222 ASCT patients who were classified based on (1) the interval between induc
Autor:
Grzegorz W. Basak, Jiri Mayer, Soledad González Muñiz, Paul Bosman, Giulia Sbianchi, Johan Lund, Jane F. Apperley, Guido Kobbe, Stig Lenhoff, Sarah Lawless, Curly Morris, Cecilia Isaksson, Esa Jantunen, Achilles Anagnostopoulos, Paul Browne, Jennifer Byrne, Didier Blaise, Simona Iacobelli, Alessandro Rambaldi, Ibrahim Yakoub-Agha, Péter Reményi, Nicolaas Schaap, Keith M.O. Wilson, Stefan Schönland, Nicolaus Kröger, Christof Scheid, Cyrille Touzeau, Laurent Garderet
Publikováno v:
Clinical Lymphoma Myeloma & Leukemia, 21, 686-693
Clinical Lymphoma, Myeloma and Leukemia, 21(10), 686-693. CIG MEDIA GROUP, LP
Clinical Lymphoma Myeloma & Leukemia, 21, 10, pp. 686-693
Clinical Lymphoma, Myeloma and Leukemia, 21(10), 686-693. CIG MEDIA GROUP, LP
Clinical Lymphoma Myeloma & Leukemia, 21, 10, pp. 686-693
The rare myelomas, immunoglobulin (Ig)D, IgM, and non-secretory, have been associated with poorer outcomes following treatment than the common myelomas (IgG, IgA, and light-chain only). We show that even with "novel" therapies, augmented with autolog
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c144cc4a414ce17f2a367c91656e25de
https://hdl.handle.net/1887/3281911
https://hdl.handle.net/1887/3281911
Autor:
Cecilia Isaksson, Fredrik Sandin, Arta Dreimane, Berit Markevärn, Johan Richter, Stig Lenhoff, Leif Stenke, Ulla Olsson-Strömberg, Anna Lübking, Mats Brune, Per Ljungman, Martin Höglund
Publikováno v:
Bone Marrow Transplantation. 54:1764-1774
Two decades after the introduction of tyrosine kinase inhibitors (TKI), a sizeable portion of patients with chronic myeloid leukemia (CML) in chronic phase (CP) still undergo allogeneic stem cell transplantation (allo-HSCT). We investigated the indic
Autor:
Edgar Faber, Maximilian Christopeit, Johan Maertens, Andrew J. Ullmann, Montserrat Rovira, Junfeng Wang, Peter J. Shaw, Malgorzata Mikulska, Luigi Rigacci, Per Ljungman, Nina Knelange, Gloria Tridello, Aitana Balaguer-Rosello, Christine Robin, Rodrigo Martino, Hermann Einsele, Riccardo Saccardi, Jenny Byrne, Kerstin Schäfer-Eckart, Jan Styczyński, Cecilia Isaksson, Dan Engelhard, Maura Faraci, Simone Cesaro, Martin Schmidt-Hieber
Publikováno v:
JOURNAL OF NEUROLOGY
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
We performed a prospective study to evaluate the types and characteristics of central nervous system (CNS) disorders in patients after hematopoietic stem cell transplantation. The study included 163 episodes of CNS disorders of which 58 (36%) were in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4329e68f275a20af374805eba35733c3
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2297
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=2297
Autor:
Didier Blaise, Soledad González Muñiz, Jane F. Apperley, Nicolaus Kröger, Péter Reményi, Nicolaas Schaap, Firoozeh Sahebi, Stig Lenhoff, Ibrahim Yakoub-Agha, Marta Krejčí, Nigel H. Russell, Giulia Sbianchi, Marek Trneny, Guido Kobbe, Wieslaw Wiktor-Jedrzejczak, Cecilia Isaksson, Christof Scheid, Stefan Schönland, Laurent Garderet, Curly Morris, Per Ljungman, Paul Browne, Linda Koster, Simona Iacobelli, James F. Sanchez, Keith Wilson
Publikováno v:
Biology of Blood and Marrow Transplantation, 24, 930-936
Biology of Blood and Marrow Transplantation, 24, 5, pp. 930-936
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (5), pp.930-936. ⟨10.1016/j.bbmt.2018.01.006⟩
Biology of Blood and Marrow Transplantation, 24, 5, pp. 930-936
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (5), pp.930-936. ⟨10.1016/j.bbmt.2018.01.006⟩
The advent of novel agents for multiple myeloma (MM) is cause for a re-examination of the incidence of second primary malignancies (SPM5). We examined the SPM rate in MM patients who were enrolled in the prospective observational CALM (Collaboration
Autor:
Mats Brune, Kristina Carlson, Magnus Göransson, Bertil Uggla, Jacek Winiarski, Per-Ola Andersson, Stig Lenhoff, Krista Vaht, Per Ljungman, Cecilia Isaksson, Anna Sandstedt
Publikováno v:
European Journal of Haematology. 100:613-620
Objectives: Antithymocyte globulin (ATG)-based immunosuppression remains a cornerstone in aplastic anaemia (AA) treatment. However, most ATG studies are not population-based and knowledge about real-world results concerning response and outcome could